A comprehensive review on equine influenza virus: Etiology, epidemiology, pathobiology, advances in developing diagnostics, vaccines, and control strategies

Frontiers in Microbiology

Volumn 9, Issue SEP, 2018, Pages

  Singh, Raj K ^a   Dhama, Kuldeep ^a   Karthik, Kumaragurubaran ^b   Khandia, Rekha ^c   Munjal, Ashok ^c   Khurana, Sandip K ^d   Chakraborty, Sandip ^e   Malik, Yashpal S ^a   Virmani, Nitin ^d   Singh, Rajendra ^a   Tripathi, Bhupendra N ^d   Munir, Muhammad ^f   van der Kolk, Johannes H ^g  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b MADRAS VETERINARY COLLEGE   (India)

^c BARKATULLAH UNIVERSITY   (India)

^d NATIONAL RESEARCH CENTRE ON EQUINES   (India)

^e Department of Veterinary Surgery and Radiology   (India)

^f LANCASTER UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF BERN   (Switzerland)

Author keywords

Control; Diagnosis; Epidemiology; Equine; Influenza virus; Pathogenesis; Prevention; Vaccine

Indexed keywords

ANTIVIRUS AGENT; DNA VACCINE; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; PREQUENZA; SUBUNIT VACCINE;

AFRICA; ASIA; AUSTRALIA; CLINICAL FEATURE; EQUINE INFLUENZA; EQUINE INFLUENZA (H3N8); EUROPE; GENETICS; INCIDENCE; INFECTION CONTROL; MOLECULAR BIOLOGY; NONHUMAN; NORTH AMERICA; PATHOLOGY; REVERSE GENETICS; REVIEW; SOUTH AMERICA; VACCINATION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

EID: 85053045735     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2018.01941     Document Type: Review

References (273)

1. Aeschbacher, S., Santschi, E., Gerber, V., Stalder, H. P., and Zanoni, R. G. (2015). Development of a real-time RT-PCR for detection of equine influenza virus. Schweiz. Arch. Tierheilkd. 157, 191-201. doi: 10.17236/sat00015
2. Alexander, D. J., and Brown, I. H. (2000). Recent zoonoses caused by influenza A viruses. Rev. Sci. Tech. 19, 197-225. doi: 10.20506/rst.19.1.1220
3. Alvarez, A. C., Brunck, M. E., Boyd, V., Lai, R., Virtue, E., Chen, W., et al. (2008). A broad spectrum, one-step reverse-transcription PCR amplification of the neuraminidase gene from multiple subtypes of influenza A virus. Virol. J. 5:77. doi: 10.1186/1743-422X-5-77
4. Alves Beuttemmüller, E., Woodward, A., Rash, A., dos Santos Ferraz, L. E., Fernandes Alfieri, A., Alfieri, A. A., et al. (2016). Characterisation of the epidemic strain of H3N8 equine influenza virus responsible for outbreaks in South America in 2012. Virol J. 13:45. doi: 10.1186/s12985-016-0503-9
5. Arthur, R. J., and Suann, C. J. (2011). Biosecurity and vaccination strategies to minimise the effect of an equine influenza outbreak on racing and breeding. Aust. Vet. J. 89, 109-113. doi: 10.1111/j.1751-0813.2011.00764.x
6. Ault, A., Zajac, A. M., Kong, W. P., Gorres, J. P., Royals, M., Wei, C. J., et al. (2012). Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies. Vaccine 30, 3965-3974. doi: 10.1016/j.vaccine.2012.03.026
7. Back, H., Berndtsson, L. T., Gröndahl, G., Ståhl, K., Pringle, J., and Zohari, S. (2016). The first reported Florida clade 1 virus in the Nordic countries, isolated from a Swedish outbreak of equine influenza in 2011. Vet. Microbiol. 184, 1-6. doi: 10.1016/j.vetmic.2015.12.010
8. Balasuriya, U. B. (2014). Type A influenza virus detection from horses by real-time RT-PCR and insulated isothermal RT-PCR. Anim. Influenza Virus 1161, 393-402. doi: 10.1007/978-1-4939-0758-8_34
9. Balasuriya, U. B., Lee, P. Y., Tiwari, A., Skillman, A., Nam, B., Chambers, T. M., et al. (2014). Rapid detection of equine influenza virus H3N8 subtype by insulated isothermal RT-PCR (iiRT-PCR) assay using the POCKIT™ nucleic acid analyzer. J. Virol. Methods 207, 66-72. doi: 10.1016/j.jviromet.2014.06.016
10. Barba, M., and Daly, J. M. (2016). The influenza NS1 protein: what do we know in equine influenza virus pathogenesis? Pathogens 5:57. doi: 10.3390/pathogens5030057
11. Barbic, L., Madic, J., Turk, N., and Daly, J. (2009). Vaccine failure caused an outbreak of equine influenza in Croatia. Vet. Microbiol. 133, 164-171. doi: 10.1016/j.vetmic.2008.06.009
12. Bayry, J. (2013). Emerging viral diseases of livestock in the developing world. Indian J. Virol. 24, 291-294. doi: 10.1007/s13337-013-0164-x
13. Baz, M., Paskel, M., Matsuoka, Y., Zengel, J., Cheng, X., Treanor, J. J., et al. (2015). A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets. J. Virol. 89, 1652-1659. doi: 10.1128/JVI.02449-14
14. Bengtsson, K. L. (2013). "Matrix M adjuvant technology, " in Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines (Boston, MA: Springer), 309-320
15. Bera, B. C., Virmani, N., Shanmugasundaram, K., Vaid, R. K., Singh, B. K., Gulati, B. R., et al. (2013). Genetic analysis of the neuraminidase (NA) gene of equine influenza virus (H3N8) from epizootic of 2008-2009 in India. Indian J. Virol. 24, 256-264. doi: 10.1007/s13337-013-0137-0
16. Bernardino, P. N., Mapes, S. M., Corbin, R., and Pusterla, N. (2016). Pyrosequencing as a fast and reliable tool to determine clade affiliation for equine influenza A virus. J. Vet. Diagn. Invest. 28, 323-326. doi: 10.1177/1040638716638123
17. Blecher, K., Nasir, A., and Friedman, A. (2011). The growing role of nanotechnology in combating infectious disease. Virulence 2, 395-401. doi: 10.4161/viru.2.5.17035
18. Bogerd, H. P., Skalsky, R. L., Kennedy, E. M., Furuse, Y., Whisnant, A. W., Flores, O., et al. (2014). Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs. J. Virol. 88, 8065-8076. doi: 10.1128/JVI.00985-14
19. Bolfa, P., Jeon, I., Loftis, A., Leslie, T., Marchi, S., Sithole, F., et al. (2017). Detection of West Nile Virus and other common equine viruses in three locations from the Leeward Islands, West Indies. Acta Trop. 174, 24-28. doi: 10.1016/j.actatropica.2017.06.023
20. Boukharta, M., Azlmat, S., Elharrak, M., and Ennaji, M. M. (2015). Multiple alignment comparison of the non-structural genes of three strains of equine influenza viruses (H3N8) isolated in Morocco. BMC Res Notes 8:471. doi: 10.1186/s13104-015-1441-0
21. Bountouri, M., Fragkiadaki, E., Ntafis, V., Kanellos, T., and Xylouri, E. (2011). Phylogenetic and molecular characterization of equine H3N8 influenza viruses from Greece (2003 and 2007): evidence for reassortment between evolutionary lineages. Virol. J. 8:350. doi: 10.1186/1743-422X-8-350
22. Breathnach, C. C., Clark, H. J., Clark, R. C., Olsen, C. W., Townsend, H. G., and Lunn, D. P. (2006). Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge. Vaccine 24, 1180-1190. doi: 10.1016/j.vaccine.2005.08.091
23. Breathnach, C. C., Rudersdorf, R., and Lunn, D. P. (2004). Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination. Vet. Immunol. Immunopathol. 98, 127-136. doi: 10.1016/j.vetimm.2003.11.004
24. Bryans, J. T., Doll, E. R., Wilson, J. C., and McCollum, W. H. (1966). Immunization for equine influenza. J. Am. Vet. Med. Assoc. 148, 413-417
25. Bryant, N. A., Paillot, R., Rash, A. S., Medcalf, E., Montesso, F., Ross, J., et al. (2010). Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak. Vet. Res. 41, 1-15. doi: 10.1051/vetres/2009067
26. Bryant, N. A., Rash, A. S., Russell, C. A., Ross, J., Cooke, A., Bowman, S., et al. (2009). Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet. Microbiol. 138, 41-52. doi: 10.1016/j.vetmic.2009.03.004
27. Bryant, N. A., Rash, A. S., Woodward, A. L., Medcalf, E., Helwegen, M., Wohlfender, F., et al. (2011). Isolation and characterisation of equine influenza viruses (H3N8) from Europe and North America from 2008 to 2009. Vet. Microbiol. 147, 19-27. doi: 10.1016/j.vetmic.2010.05.040
28. Burashev, Y., Strochkov, V., Sultankulova, K., Orynbayev, M., Sansyzbay, A., Sandybayev, N., et al. (2018). Complete genome sequencing of two equine influenza A(H3N8) virus strains isolated in Kazakhstan. Genome Announc. 6, e00574-e00518. doi: 10.1128/genomeA.00574-18
29. Burnell, F. J., Holmes, M. A., Roiko, A. H., Lowe, J. B., Heil, G. L., White, S. K., et al. (2014). Little evidence of human infection with equine influenza during the 2007 epizootic, Queensland, Australia. J. Clin. Virol. 59, 100-103. doi: 10.1016/j.jcv.2013.11.011
30. Chambers, T. M. (1992). Cross reactivity of existing influenza vaccine with a new strain of equine influenza virus from China. Vet. Rec. 31:388. doi: 10.1136/vr.131.17.388
31. Chambers, T. M. (2014). "A brief introduction to equine influenza and equine influenza viruses, " in Animal Influenza Virus. Methods in Molecular Biology, ed E. Spackman (New York, NY: Springer), Chapter 31, 365-370
32. Chambers, T. M., and Balasuriya, U. B. R. (2016). "Equine influenza virus, " in Molecular Detection of Animal Viral Pathogens, ed D. Liu (Boca Raton, FL: CRC Press), 383-392
33. Chambers, T. M., Holland, R. E., Tudor, L. R., Townsend, H. G. G., Cook, A., Bogdan, J., et al. (2001). A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge. Equine Vet. J. 33, 630-636. doi: 10.2746/042516401776249291
34. Chambers, T. M., Holland, R. E. Jr., and Lai, A. C. K. (1995). Equine influenza-current veterinary perspectives, part 2. Equine Pract. 17, 26-30
35. Chambers, T. M., Quinlivan, M., Sturgill, T., Cullinane, A., Horohov, D. W., Zamarin, D., et al. (2009). Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses. Equine Vet. J. 41, 87-92. doi: 10.2746/042516408X371937
36. Chambers, T. M., and Reedy, S. E. (2014a). Equine influenza diagnosis: sample collection and transport. Methods Mol. Biol. 1161, 371-377. doi: 10.1007/978-1-4939-0758-8_32
37. Chambers, T. M., and Reedy, S. E. (2014b). Equine influenza culture methods. Methods Mol. Biol. 1161, 403-410 doi: 10.1007/978-1-4939-0758-8_35
38. Chambers, T. M., and Reedy, S. E. (2014c). Equine influenza serological methods. Methods Mol. Biol. 1161, 411-422. doi: 10.1007/978-1-4939-0758-8_36
39. Chambers, T. M., Shortridge, K. F., Li, P. H., Powell, D. G., and Watkins, K. L. (1994). Rapid diagnosis of equine influenza by the directigen FLU-A enzyme immunoassay. Vet. Rec. 135, 275-279. doi: 10.1136/vr.135.12.275
40. Chien, C. Y., Xu, Y., Xiao, R., Aramini, J. M., Sahasrabudhe, P. V., Krug, R. M., et al. (2004). Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. Biochemistry 43, 1950-1962. doi: 10.1021/bi030176o
41. Collins, P. J., Vachieri, S. G., Haire, L. F., Ogrodowicz, R. W., Martin, S. R., Walker, P. A., et al. (2014). Recent evolution of equine influenza and the origin of canine influenza. Proc. Natl. Acad. Sci. U.S.A. 111, 11175-11180. doi: 10.1073/pnas.1406606111
42. Cook, R. F., Sinclair, R., and Mumford, J. A. (1988). Detection of influenza nucleoprotein antigen in nasal secretions from horses infected with A/equine influenza (H3N8) viruses. J. Virol. Methods 20, 1-12. doi: 10.1016/0166-0934(88)90034-1
43. Cooke, G. (2013). Vaccination for equine influenza: the sports regulator's viewpoint. Equine Vet. J. 45, 770-771. doi: 10.1111/evj.12151
44. Couch, R. B., Douglas, R. G., Rossen, R., and Kasel, J. (1969). "Role of secretory antibody in influenza, " in The Secretory Immune System (Washington, DC: U.S. Dept. of Public Health), 93-112
45. Cowled, B., Ward, M. P., Hamilton, S., and Garner, G. (2009). The equine influenza epidemic in Australia: Spatial and temporal descriptive analyses of a large propagating epidemic. Prev. Vet. Med. 92, 60-70. doi: 10.1016/j.prevetmed.2009.08.006
46. Crawford, P. C., Dubovi, E. J., Castleman, W. L., Stephenson, I., Gibbs, E. P., Chen, L., et al. (2005). Transmission of equine influenza virus to dogs. Science 310, 482-485. doi: 10.1126/science.1117950
47. Crispe, E., Finlaison, D. S., Hurt, A. C., and Kirkland, P. D. (2011). Infection of dogs with equine influenza virus: evidence for transmission from horses during the Australian outbreak. Aust. Vet. J. 89, 27-28. doi: 10.1111/j.1751-0813.2011.00734.x
48. Crouch, C. F., Daly, J., Hannant, D., Wilkins, J., and Francis, M. J. (2004). Immune responses and protective efficacy in ponies immunized with and equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus. Vaccine 23, 418-425. doi: 10.1016/j.vaccine.2004.01.074
49. Crouch, C. F., Daly, J., Henley, W., Hannant, D., Wilkins, J., and Francis, M. J. (2005). The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses. Vet. Immunol. Immunopathol. 108, 345-355. doi: 10.1016/j.vetimm.2005.06.009
50. Cullinane, A., Elton, D., and Mumford, J. (2010). Equine influenza-surveillance and control. Influenza Other Respir. Viruses 4, 339-344. doi: 10.1111/j.1750-2659.2010.00176.x
51. Cullinane, A., and Newton, J. R. (2013). Equine influenza-a global perspective. Vet. Microbiol. 167, 205-214. doi: 10.1016/j.vetmic.2013.03.029
52. Cullinane, A. A., Barr, B., Bernard, W., Duncan, J. L., Mulcahy, G., Smith, M., et al. (2006). "Infectious diseases (chapter 1): equine influenza, " in The Equine Manual. 2nd Edn, eds A. J. Higgins and J. R. Snyder (Philadelphia, PA: Elsevier Saunders), 13-18
53. Daly, J. M., Blunden, A. S., Macrae, S., Miller, J., Bowman, S. J., Kolodziejek, J., et al. (2008). Transmission of equine influenza virus to English foxhounds. Emerg. Infect. Dis. 14, 461-464. doi: 10.3201/eid1403.070643
54. Daly, J. M., Lai, A. C., Binns, M. M., Chambers, T. M., Barrandeguy, M., and Mumford, J. A. (1996). Antigenic and genetic evolution of equine H3N8 influenza A viruses. J. Gen. Virol. 77, 661-671. doi: 10.1099/0022-1317-77-4-661
55. Daly, J. M., MacRae, S., Newton, J. R., Wattrang, E., and Elton, D. M. (2011). Equine influenza: a review of an unpredictable virus. Vet. J. 189, 7-14. doi: 10.1016/j.tvjl.2010.06.026
56. Daly, J. M., and Murcia, P. R. (2018). Strategic implementation of vaccines for control of equine influenza. Equine Vet. J. 50, 153-154. doi: 10.1111/evj.12794
57. Daly, J. M., Newton, J. R., and Mumford, J. A. (2004). Current perspectives on control of equine influenza. Vet. Res. 35, 411-423. doi: 10.1051/vetres:2004023
58. Daly, J. M., Whitwell, K. E., Millera, J., Dowd, G., Cardwell, J. M., and Smith, K. C. (2006). Investigation of equine influenza cases exhibiting neurological disease: coincidence or association? J. Comp. Pathol. 134, 231-235. doi: 10.1016/j.jcpa.2005.09.001
59. Damiani, A. M., Scicluna, M. T., Ciabatti, I., Cardeti, G., Sala, M., Vulcano, G., et al. (2008). Genetic characterization of equine influenza viruses isolated in Italy between 1999 and 2005. Virus Res. 131, 100-105. doi: 10.1016/j.virusres.2007.08.001
60. Dhama, K., Chakraborty, S., Tiwari, R., Verma, A. K., Saminathan, M., Amarpal, M., et al. (2014). A concept paper on novel technologies boosting production and safeguarding health of humans and animals. Res. Opin. Anim. Vet. Sci. 4, 353-370
61. Dhama, K., Chakraborty, S., Wani, M. Y., Verma, A. K., Deb, R., et al. (2013). Novel and emerging therapies safeguarding health of humans and their companion animals: a review. Pak. J. Biol. Sci. 16, 101-111. doi: 10.3923/pjbs.2013.101.111
62. Dhama, K., Karthik, K., Khandia, R., Munjal, A., Tiwari, R., Rana, R., et al. (2018). Medicinal and therapeutic potential of herbs and plant metabolites/extracts countering viral pathogens-current knowledge and future prospects. Curr. Drug Metab. 19, 236-263. doi: 10.2174/1389200219666180129145252
63. Dhama, K., Mahendran, M., Gupta, P. K., and Rai, A. (2008). DNA Vaccines and their applications in veterinary practice: current perspectives. Vet. Res. Commun. 32, 341-356. doi: 10.1007/s11259-008-9040-3
64. Diallo, I., Read, A. J., and Kirkland, P. D. (2011). Positive results in a real-time PCR for type A influenza associated with the use of an inactivated vaccine. Aust. Vet. J. 89, 145-146. doi: 10.1111/j.1751-0813.2011.00746.x
65. Diaz-Mendez, A., Viel, L., Hewson, J., Doig, P., Carman, S., Chambers, T., et al. (2010). Surveillance of equine respiratory viruses in Ontario. Can. J. Vet. Res. 74, 271-278
66. Dominguez, M., Münstermann, S., Murray, G., and Timoney, P. (2015). High-health, high-performance' horses: risk mitigation strategies for OIE-listed diseases. Rev. Sci. Tech. 34, 837-848. doi: 10.20506/rst.34.3.2399
67. Donofrio, J. C., Coonrod, J. D., and Chambers, T. M. (1994). Diagnosis of equine influenza by the polymerase chain reaction. J. Vet. Diagn. Invest. 6, 39-43. doi: 10.1177/104063879400600108
68. Easterday, B. C., Hinshaw, V. S., and Halvorson, D. A. (1997). "Influenza, " in Diseases of Poultry, 10th Edn., eds. B. W. Calnek, H. J. Barnes, C. W. Beard, L. R. McDougald, and Y. M. Saif (London: Mosby-Wolfe), 583-605
69. Edelman, R. (2000). "An overview of adjuvant use, " in Vaccine Adjuvants: Preparation Methods and Research Protocols, Vol. 42 (Totowa, NJ: Humana Press Inc.), 1-27
70. Elbadry, M. A., Merrill, M. M., Ma, M. M., Ma, M. J., Lu, J. H., Cao, W. C., et al. (2014). China's great wall, Israel's bar lev line, and passive infectious disease surveillance. Mil. Med. Res. 1, 15. doi: 10.1186/2054-9369-1-15
71. Elton, D., Bruce, E. A., Bryant, N., Wise, H. M., MacRae, S., Rash, A., et al. (2013). The genetics of virus particle shape in equine influenza A virus. Influenza Other Respir. Viruses 7, 81-89. doi: 10.1111/irv.12197
72. Elton, D., and Bryant, N. (2011). Facing the threat of equine influenza. Equine Vet. J. 43, 250-258. doi: 10.1111/j.2042-3306.2010.00357.x
73. Elton, D., and Cullinane, A. (2013). Equine influenza: antigenic drift and implications for vaccines. Equine Vet. J. 45, 768-769. doi: 10.1111/evj.12148
74. Favaro, P. F., Fernandes, W. R., Reischak, D., Brandão, P. E., Silva, S. O. S., and Richtzenhain, L. J. (2018). Evolution of equine influenza viruses (H3N8) during a Brazilian outbreak, 2015. Braz. J. Microbiol. 49, 336-346. doi: 10.1016/j.bjm.2017.07.003
75. Feng, K. H., Gonzalez, G., Deng, L., Yu, H., Tse, V. L., Huang, L., et al. (2015). Equine and canine influenza H3N8 viruses show minimal biological differences despite phylogenetic divergence. J. Virol. 89, 6860-6873. doi: 10.1128/JVI.00521-15
76. Feng, K. H., Sun, M., Iketani, S., Holmes, E. C., and Parrish, C. R. (2016). Comparing the functions of equine and canine influenza H3N8 virus PA-X proteins: suppression of reporter gene expression and modulation of global host gene expression. Virology 496, 138-146. doi: 10.1016/j.virol.2016.06.001
77. Ferguson, L., Olivier, A. K., Genova, S., Epperson, W. B., Smith, D. R., Schneider, L., et al. (2016). Pathogenesis of influenza D virus in cattle. J. Virol. 90, 5636-5642. doi: 10.1128/JVI.03122-15
78. Foord, A. J., Selleck, P., Colling, A., Klippel, J., Middleton, D., and Heine, H. G. (2009). Real-time RT-PCR for detection of equine influenza and evaluation using samples from horses infected with A/equine/Sydney/2007 (H3N8). Vet. Microbiol. 137, 1-9. doi: 10.1016/j.vetmic.2008.12.006
79. Fougerolle, S., Legrand, L., Garrett, D., Birand, I., Foursin, M., D'Ablon, X., et al. (2016). Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in thoroughbred foals. Vaccine 34, 3787-3795. doi: 10.1016/j.vaccine.2016.05.068
80. Fougerolle, S., Legrand, L., Lecouturier, F., Sailleau, C., Paillot, R., Hans, A., et al. (2017). Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors. Virology 505, 210-217. doi: 10.1016/j.virol.2017.02.003
81. Frazer, J. L., Perkins, N. R., and Pitt, D. (2011). Role of personal decontamination in preventing the spread of equine influenza. Aust. Vet. J. 89, 120-124. doi: 10.1111/j.1751-0813.2011.00763.x
82. Gahan, J., Garvey, M., Gildea, S., Gür, E., Kagankaya, A., and Cullinane, A. (2017). Whole-genome sequencing and antigenic analysis of the first equine influenza virus identified in Turkey. Influenza Other Respir. Viruses 12, 374-385. doi: 10.1111/irv.12485
83. Gaíva e Silva, L., Borges, A. M., Villalobos, E. M., Lara Mdo, C., Cunha, E. M., de Oliveira, A. C., et al. (2014). Prevalence of antibodies against influenza virus in non-vaccinated equines from the Brazilian Pantanal. Rev. Inst. Med. Trop. Sao Paulo 56, 487-492. doi: 10.1590/S0036-46652014000600006
84. Galvin, P., Gildea, S., Arkins, S., Walsh, C., and Cullinane, A. (2013). The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA). Influenza Other Respir. Viruses 7, 73-80. doi: 10.1111/irv.12195
85. Galvin, P., Gildea, S., Nelly, M., Quinlivan, M., Arkins, S., Walsh, C., et al. (2014). The evaluation of three diagnostic tests for the detection of equine influenza nucleoprotein in nasal swabs. Influenza Other Respir. Viruses 8, 376-383. doi: 10.1111/irv.12235
86. Gamoh, K., and Nakamura, S. (2017). Update of inactivated equine influenza vaccine strain in Japan. J. Vet. Med. Sci. 79, 649-653. doi: 10.1292/jvms.16-0558
87. Garrett, D., Montesso, F., Fougerolle, S., Lopez-Alvarez, M. R., Birand, I., De Bock, M., et al. (2017). Refinement of the equine influenza model in the natural host: a meta-analysis to determine the benefits of individual nebulisation for experimental infection and vaccine evaluation in the face of decreased strain pathogenicity. Vet. Microbiol. 211, 150-159. doi: 10.1016/j.vetmic.2017.10.010
88. Gerber, H. (1970). "Clinical features, sequelae and epidemiology of equine influenza, " in Proceedings of the 2nd International Conference on Equine Infectious Diseases, Paris, 1969, New York, 1970, ed J. T. Bryans (Basel: Karger), 63-80
89. Gibbs, E. P., and Anderson, T. C. (2010). Equine and canine influenza: a review of current events. Anim. Health Res. Rev. 11, 43-51. doi: 10.1017/S1466252310000046
90. Gildea, S., Arkins, S., and Cullinane, A. (2010). A comparative antibody study of the potential susceptibility of thoroughbred and non-thoroughbred horse populations in Ireland to equine influenza virus. Influenza Other Respir. Viruses 4, 363-372. doi: 10.1111/j.1750-2659.2010.00163.x
91. Gildea, S., Arkins, S., and Cullinane, A. (2011). Management and environmental factors involved in equine influenza outbreaks in Ireland 2007-2010. Equine Vet. J. 43, 608-617. doi: 10.1111/j.2042-3306.2010.00333.x
92. Gildea, S., Garvey, M., Lyons, P., Lyons, R., Gahan, J., Walsh, C., et al. (2018). Multifocal equine influenza outbreak with vaccination breakdown in thoroughbred racehorses. Pathogens 7:E43. doi: 10.3390/pathogens7020043
93. Gildea, S., Quinlivan, M., Arkins, S., and Cullinane, A. (2012). The molecular epidemiology of equine influenza in Ireland from 2007-2010 and its international significance. Equine Vet. J. 44, 387-392. doi: 10.1111/j.2042-3306.2011.00472.x
94. Gildea, S., Sanchez Higgins, M. J., Johnson, G., Walsh, C., and Cullinane, A. (2016). Concurrent vaccination against equine influenza and equine herpes virus-a practical approach. Influenza Other Respir. Viruses 10, 433-437. doi: 10.1111/irv.12396
95. Gonzalez, G., Marshall, J. F., Morrell, J., Robb, D., McCauley, J. W., Perez, D. R., et al. (2014). Infection and pathogenesis of canine, equine, and human influenza viruses in canine tracheas. J. Virol. 88, 9208-9219. doi: 10.1128/JVI.00887-14
96. Gora, I. M., Kwasnik, M., Zmudzinski, J. F., and Rozek, W. (2017). Chorioallantoic membranes of embryonated chicken eggs as an alternative system for isolation of equine influenza virus. Virol. J. 14, 120. doi: 10.1186/s12985-017-0788-3
97. Guo, Y., Wang, M., Kawaoka, Y, Gorman, O, Ito, T, and Saito, T. (1992). Characterization of new avian like influenza A virus from horses in China. Virology 188:245. doi: 10.1016/0042-6822(92)90754-D
98. Gupta, A. K., Anita, A., and Vandanajay, B. (2003). Detection of equine influenza viral genome by RT-PCR and RNA-DNA hybridization. Indian J. Biotech. 2, 214-219
99. Hale, B. G., Randall, R. E., Ortín, J., and Jackson, D. (2008). The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89, 2359-2376. doi: 10.1099/vir.0.2008/004606-0
100. Hayward, J. J., Dubovi, E. J., Scarlett, J. M., Janeczko, S., Holmes, E. C., and Parrish, C. R. (2010). Microevolution of canine influenza virus in shelters and its molecular epidemiology in the United States. J. Virol. 84, 12636-12645. doi: 10.1128/JVI.01350-10
101. Heldens, J. G., Pouwels, H. G., Derks, C. G., Van de Zande, S. M., and Hoeijmakers, M. J. (2009). The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap. Vaccine 27, 5530-5537. doi: 10.1016/j.vaccine.2009.06.085
102. Heldens, J. G., Pouwels, H. G., and van Loon, A. A. (2004). Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95). Vet. J. 167, 150-157. doi: 10.1016/S1090-0233(03)00028-5
103. Heldens, J. G., van Loon, A. A., and van de Zande, S. (2007). Is there a benefit from an early booster vaccination in the control of equine influenza? Vet. J. 174, 592-598. doi: 10.1016/j.tvjl.2007.03.004
104. Hemann, E. A., Kang, S. M., and Legge, K. L. (2013). Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination. J. Immunol. 191, 2486-2494. doi: 10.4049/jimmunol.1300954
105. Hinshaw, V. S., Olsen, C. W., Dybdahl-Sissoko, N., and Evans, D. (1994). Apoptosis: a mechanism of cell killing by influenza A and B viruses. J. Virol. 68, 3667-3673
106. Holland, R. E. (2003). Equine Influenza. Art. No: 4584. Available online at: www.thehorse.com
107. Horspool, L. J., and King, A. (2013). Equine influenza vaccines in Europe: a view from the animal health industry. Equine Vet. J. 45, 774-775. doi: 10.1111/evj.12171
108. Hughes, J., Allen, R. C., Baguelin, M., Hampson, K., Baillie, G. J., Elton, D., et al. (2012). Transmission of equine influenza virus during an outbreak is characterized by frequent mixed infections and loose transmission bottlenecks. PLoS Pathog. 8:e1003081. doi: 10.1371/journal.ppat.1003081
109. Ibañez, L. I., Caldevilla, C. A., Paredes Rojas, Y., and Mattion, N. (2018). Genetic and subunit vaccines based on the stem domain of the equine influenza hemagglutinin provide homosubtypic protection against heterologous strains. Vaccine 36, 1592-1598. doi: 10.1016/j.vaccine.2018.02.019
110. Ito, M., Nagai, M., Hayakawa, Y., Komae, H., Murakami, N., Yotsuya, S., et al. (2008). Genetic analyses of an H3N8 influenza virus isolate, causative strain of the outbreak of equine influenza at the Kanazawa Racecourse in Japan in 2007. J. Vet. Med. Sci. 70, 899-906. doi: 10.1292/jvms.70.899
111. Ito, T., and Kawaoka, Y. (2000). Host-range barrier of Influenza A viruses. Vet. Microbiol. 74, 71-75. doi: 10.1016/S0378-1135(00)00167-X
112. Jagger, B. W., Wise, H. M., Kash, J. C., Walters, K. A., Wills, N. M., Xiao, Y. L., et al. (2012). An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337, 199-204. doi: 10.1126/science.1222213
113. Joseph, U., Su, Y. C., Vijaykrishna, D., and Smith, G. J. (2017). The ecology and adaptive evolution of influenza A interspecies transmission. Influenza Other Respir. Viruses 11, 74-84. doi: 10.1111/irv.12412
114. Junquera, E. C., Mateos-Hernández, L., de la Fuente, J., and de la Lastra, J. M. (2014). Recent advances in the development of anti-Infective prophylactic and/or therapeutic agents based on toll-like receptor (TLRs). Recent Pat. Antiinfect. Drug Discov. 9, 14-24. doi: 10.2174/1574891X09666140616164918
115. Kapoor, S., and Dhama, K. (2014). Insight into Influenza Viruses of Animals and Humans. Cham: Springer International Publishing, A. G., 1-222
116. Karamendin, K., Kydyrmanov, A., Kasymbekov, Y., Khan, E., Daulbayeva, K., Asanova, S., et al. (2014). Continuing evolution of equine influenza virus in Central Asia, 2007-2012. Arch. Virol. 159, 2321-2327. doi: 10.1007/s00705-014-2078-3
117. Kawaoka, Y., Bean, W. J., and Webster, R. G. (1989). Evolution of the hemagglutinin of equine H3 influenza viruses. Virology 169, 283-292. doi: 10.1016/0042-6822(89)90153-0
118. Khan, A., Mushtaq, M. H., Ahmad, M. U. D., Nazir, J., Farooqi, S. H., and Khan, A. (2017). Molecular epidemiology of a novel re-assorted epidemic strain of equine influenza virus in Pakistan in 2015-16. Virus Res. 240, 56-63. doi: 10.1016/j.virusres.2017.07.022
119. Khurelbaatar, N., Krueger, W. S., Heil, G. L., Darmaa, B., Ulziimaa, D., Tserennorov, D., et al. (2013). Sparse evidence for equine or avian influenza virus infections among Mongolian adults with animal exposures. Influenza Other Respir. Viruses 7, 1246-1250. doi: 10.1111/irv.12148
120. Khurelbaatar, N., Krueger, W. S., Heil, G. L., Darmaa, B., Ulziimaa, D., Tserennorov, D., et al. (2014). Little evidence of avian or equine influenza virus infection among a cohort of Mongolian adults with animal exposures, 2010-2011. PLoS ONE 9:e85616. doi: 10.1371/journal.pone.0085616
121. Kinsley, R., Scott, S. D., and Daly, J. M. (2016). Controlling equine influenza: traditional to next generation serological assays. Vet. Microbiol. 187, 15-20. doi: 10.1016/j.vetmic.2016.03.006
122. Kirkland, P. D., and Delbridge, G. (2011). Use of a blocking ELISA for antibodies to equine influenza virus as a test to distinguish between naturally infected and vaccinated horses: proof of concept studies. Aust. Vet. J. 89, 45-46. doi: 10.1111/j.1751-0813.2011.00743.x
123. Kirkland, P. D., Finlaison, D. S., Crispe, E., and Hurt, A. C. (2010). Influenza virus transmission from horses to dogs, Australia. Emerg. Infect. Dis. 16, 699-702. doi: 10.3201/eid1604.091489
124. Koel, B. F., Burke, D. F., Bestebroer, T. M., van der Vliet, S., Zondag, G. C., Vervaet, G., et al. (2013). Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342, 976-979. doi: 10.1126/science.1244730
125. Krumbholz, A., Philipps, A., Oehring, H., Schwarzer, K., Eitner, A., Wutzler, P., et al. (2011). Current knowledge on PB1-F2 of influenza A viruses. Med. Microbiol. Immunol. 200, 69-75. doi: 10.1007/s00430-010-0176-8
126. Kumar, N., Bera, B. C., Greenbaum, B. D., Bhatia, S., Sood, R., Selvaraj, P., et al. (2016). Revelation of influencing factors in overall codon usage bias of equine influenza viruses. PLoS ONE 11:e0154376. doi: 10.1371/journal.pone.0154376
127. Kwasnik, M., Gora, I. M., Rola, J., Zmudzinski, J. F., and Rozek, W. (2016). NS-gene based phylogenetic analysis of equine influenza viruses isolated in Poland. Vet. Microbiol. 182, 95-101. doi: 10.1016/j.vetmic.2015.10.028
128. Laabassi, F. (2016). "Epidemiology of equine influenza viruses, " in Epidemiology of Communicable and Non-Communicable Diseases-Attributes of Lifestyle and Nature on Humankind, ed F. Kasenga (InTech). Available online at: https://www.intechopen.com/books/epidemiology-of-communicable-and-non-communicable-diseases-attributes-of-lifestyle-and-nature-on-humankind/epidemiology-of-equine-influenza-viruses
129. Lai, A. C., Chambers, T. M., Holland, R. E. Jr., Morley, P. S., Haines, D. M., Townsend, H. G., et al. (2001). Diverged evolution of recent equine-2 influenza (H3N8) viruses in the western hemisphere. Arch. Virol. 146, 1063-1074. doi: 10.1007/s007050170106
130. Lamb, R. A., and Lai, C. J. (1980). Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell 21, 475-485. doi: 10.1016/0092-8674(80)90484-5
131. Landolt, G. A. (2014). Equine influenza virus. Vet. Clin. N. Am. Equine Pract. 30, 507-522. doi: 10.1016/j.cveq.2014.08.003
132. Landolt, G. A., Hussey, S. B., Kreutzer, K., Quintana, A., and Lunn, D. P. (2010). Low-dose DNA vaccination into the submandibular lymph nodes in ponies. Vet. Rec. 167, 302-303. doi: 10.1136/vr.c3891
133. Landolt, G. A., Townsend, H. G. G., and Lunn, D. P. (2007). "Equine influenza infection, " in Equine Infectious Diseases, eds D. C. Sellon, and M. T. Long (Philadelphia, PA: Saunders; Elsevier Inc.), Chapter 12, 124-134
134. Larson, K. R., Heil, G. L., Chambers, T. M., Capuanod, A., White, S. K., and Gray, G. C. (2015). Serological evidence of equine influenza infections among persons with horse exposure, Iowa. J. Clin. Virol. 67, 78-83. doi: 10.1016/j.jcv.2015.04.009
135. Law, J. (1874). "Influenza in horses, " in Report of the Commissioner of Agriculture for the Year 1872, ed Commission of Agriculture (Washington, DC: Government Printing Office), 203-248
136. Lee, E., Kim, E. J., Shin, Y. K., and Song, J. Y. (2016). Design and testing of multiplex RT-PCR primers for the rapid detection of influenza A virus genomic segments: application to equine influenza virus. J. Virol. Methods 228, 114-122. doi: 10.1016/j.jviromet.2015.11.012
137. Lee, J., Park, J. H., and Min, J. Y. (2017). A naturally truncated NS1 protein of influenza A virus impairs its interferon-antagonizing activity and thereby confers attenuation in vitro. Arch. Virol. 162, 13-21. doi: 10.1007/s00705-016-2966-9
138. Legrand, L. J., Pitel, P. H., Cullinane, A. A., Fortier, G. D., and Pronost, S. L. (2015). Genetic evolution of equine influenza strains isolated in France from 2005 to 2010. Equine Vet. J. 47, 207-211. doi: 10.1111/evj.12244
139. Lewis, N. S., Anderson, T. K., Kitikoon, P., Skepner, E., Burke, D. F., and Vincent, A. L. (2014). Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U.S. Swine. J. Virol. 88, 4752-4763. doi: 10.1128/JVI.03805-13
140. Lewis, N. S., Daly, J. M., Russell, C. A., Horton, D. L., Skepner, E., Bryant, N. A., et al. (2011). Antigenic and genetic evolution of equine influenza A (H3N8) virus from 1968 to 2007. J. Virol. 85, 12742-12749. doi: 10.1128/JVI.05319-11
141. Lin, C., Holland, R. E. Jr., Donofrio, J. C., McCoy, M. H., Tudor, L. R., and Chambers, T. M. (2002). Caspase activation in equine influenza virus induced apoptotic cell death. Vet. Microbiol. 84, 357-365. doi: 10.1016/S0378-1135(01)00468-0
142. Livesay, G. J., O'neill, T., Hannant, D., Yadav, M. P., and Mumford, J. A. (1993). The outbreak of equine influenza (H3N8) in the United Kingdom in 1989; diagnostic use of an antigen capture ELISA. Vet. Rec. 133, 515-519
143. Lu, Z., Chambers, T. M., Boliar, S., Branscum, A. J., Sturgill, T. L., Timoney, P. J., et al. (2009). Development and evaluation of one-step TaqMan real-time reverse transcription-PCR assays targeting nucleoprotein, matrix, and hemagglutinin genes of equine influenza virus. J. Clin. Microbiol. 47, 3907-3913. doi: 10.1128/JCM.00598-09
144. Lunn, D. P., Soboll, G., Schram, B. R., Quass, J., McGregor, M. W., Drape, R. J., et al. (1999). Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine 17, 2245-2258. doi: 10.1016/S0264-410X(98)00496-4
145. Major, D. A. (2011). Hygiene practices to prevent the spread of equine influenza by humans. Aust. Vet. J. 89, 124-125. doi: 10.1111/j.1751-0813.2011.00765.x
146. Malik, Y. S., Sharma, K., Jeena, L. M., Kumar, N., Sircar, S., Rajak, K. K., et al. (2013). Toll-like receptors: the innate immune receptors with ingenious anti-viral paradigm. South Asian J. Exp. Biol. 3, 207-213
147. Manjrekar, S. L., Gorhe, D. S., and Paranjape, V. L. (1965). Observations on the coughing outbreak "Newmarket cough" in the race horses in Bombay. Indian Vet. J. 42, 461-464
148. Mathew, T., Dhama, K., Pawaiya, R. V. S., and Mahendran, M. (2010). "Equine influenza, " in Advances in Medical and Veterinary Virology, Immunology, and Epidemiology-Vol. 7: Tropical Viral Diseases of Large Domestic Animals-Part 1, ed T. Mathew (West Orange, NJ; United Kingdom: Thajema Publishers; Xlibris Corporation), Chapter 133-151
149. Mathew, T., Mahendran, M., and Dhama, K. (2006). "Equine influenza (Chapter VII), " in Advances in Medical & Veterinary Virology, Immunology and Epidemiology, Vol. 6: Influenza and it's Public Health Significance, eds: T. M. Mathew and T. Mathew (West Orange, NJ: Thajema Publishers), 112-129
150. McAuley, J. L., Kedzierska, K., Brown, L. E., and Shanks, G. D. (2015). Host immunological factors enhancing mortality of young adults during the 1918 influenza pandemic. Front. Immunol. 6:419. doi: 10.3389/fimmu.2015.00419
151. McKinstry, K. K., Dutton, R. W., Swain, S. L., et al. (2013). Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful. Arch. Immunol. Ther. Exp. 61, 341-353. doi: 10.1007/s00005-013-0236-z
152. Meeusen, E. N., Walker, M. J., Peters, A., Pastoret, P. P., and Jungersen, G. (2007). Current status of veterinary vaccines. Clin. Microbiol. Rev. 20, 3489-3510. doi: 10.1128/CMR.00005-07
153. Meseko, C. A., Ehizibolo, D. O., Nwokike, E. C., and Wungak, Y. S. (2016). Serological evidence of equine influenza virus in horse stables in Kaduna, Nigeria. J. Equine Sci. 27, 99-105. doi: 10.1294/jes.27.99
154. Minke, J. M., Audonnet, J. C., and Fischer, L. (2004). Equine viral vaccines: the past, present and future. Vet. Res. 35, 425-443. doi: 10.1051/vetres:2004019
155. Minke, J. M., Toulemonde, C. E., Coupier, H., Guigal, P. M., Dinic, S., Sindle, T., et al. (2007). Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equineinfluenza H3N8 virus in the protection of ponies from viral challenge. Am. J. Vet. Res. 68, 213-219. doi: 10.2460/ajvr.68.2.213
156. Moattari, A., Ashrafi, H., Kadivar, M. R., Kheiri, M. T., Shahidi, M., Arabpour, M., et al. (2010). Antigenic variations of human influenza virus in Shiraz, Iran. Indian J. Med. Microbiol. 28, 114-119. doi: 10.4103/0255-0857.62486
157. Morens, D. M., and Taubenberger, J. K. (2010). Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine. Influenza Other Respir. Viruses 4, 327-337. doi: 10.1111/j.1750-2659.2010.00148.x
158. Morley, P. S., Townsend, H. G., Bogdan, J. R., and Haines, D. M. (2000). Descriptive epidemiologic study of disease associated with influenza virus infections during three epidemics in horses. J. Am. Vet. Med. Assoc. 216, 535-544. doi: 10.2460/javma.2000.216.535
159. Mumford, J. A. (1990). The diagnosis and control of equine influenza, Proc. Am. Assoc. Equine Pract. 36:377
160. Mumford, J. A., and Wood, J. (1993). Conference report on WHO/OIE meeting: consultation on newly emerging strains of equine influenza. Vaccine 11, 1172-1175. doi: 10.1016/0264-410X(93)90092-C
161. Murcia, P. R., Baillie, G. J., Daly, J., Elton, D., Jervis, C., Mumford, J. A., et al. (2010). Intra-and interhost evolutionary dynamics of equine influenza virus. J. Virol. 84, 6943-6954. doi: 10.1128/JVI.00112-10
162. Murcia, P. R., Baillie, G. J., Stack, J. C., Jervis, C., Elton, D., Mumford, J. A., et al. (2013). Evolution of equine influenza virus in vaccinated horses. J. Virol. 87, 4768-4771. doi: 10.1128/JVI.03379-12
163. Na, W., Kang, B., Kim, H. I., Hong, M., Park, S. J., Jeoung, H. Y., et al. (2014). Isolation and genetic characterization of naturally NS-truncated H3N8 equine influenza virus in South Korea. Epidemiol. Infect. 142, 759-766. doi: 10.1017/S095026881300143X
164. Na, W., Yeom, M., Yuk, H., Moon, H., Kang, B., and Song, D. (2016). Influenza virus vaccine for neglected hosts: horses and dogs. Clin. Exp. Vaccine Res. 5, 117-124. doi: 10.7774/cevr.2016.5.2.117
165. Nedland, H., Wollman, J., Sreenivasan, C., Quast, M., Singrey, A., Fawcett, L., et al. (2018). Serological evidence for the co-circulation of two lineages of influenza D viruses in equine populations of the Midwest United States. Zoonoses Public Health 65, e148-e154. doi: 10.1111/zph.12423
166. Nelson, K. M., Schram, B. R., and McGregor, M. W. (1998). Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 16, 1306-1313. doi: 10.1016/S0264-410X(98)00009-7
167. Nemoto, M., Yamanaka, T., Bannai, H., Tsujimura, K., and Kokado, H. (2018). Complete genomic sequences of H3N8 equine influenza virus strains used as vaccine strains in Japan. Genome Announc. 6, e00172-e00118. doi: 10.1128/genomeA.00172-18
168. Nemoto, M., Yamanaka, T., Bannai, H., Tsujimura, K., Kondo, T., and Matsumura, T. (2011). Development and evaluation of a reverse transcription loop-mediated isothermal amplification assay for H3N8 equine influenza virus. J. Virol. Methods 178, 239-242. doi: 10.1016/j.jviromet.2011.07.015
169. Nemoto, M., Yamanaka, T., Bannai, H., Tsujimura, K., Kondo, T., and Matsumura, T. (2012). Development of a reverse transcription loop-mediated isothermal amplification assay for H7N7 equine influenza virus. J. Vet. Med. Sci. 74, 929-931. doi: 10.1292/jvms.11-0541
170. Newton, J. R., and Mumford, J. A. (2005). "Equine influenza, " in Infectious Diseases of Livestock, Vol. 1, ed J. A. W. Coetzer and R. C. Tustin (Oxford: Oxford University Press), 766-774
171. Newton, R., Cooke, A., Elton, D., Bryant, N., Rash, A., Bowman, S., et al. (2007). Canine influenza virus: cross-species transmission from horses. Vet. Rec. 161, 142-143. doi: 10.1136/vr.161.4.142-a
172. Nogales, A., and Martínez-Sobrido, L. (2017). Reverse genetics approaches for the development of influenza vaccines. Int. J. Mol. Sci. 18:20. doi: 10.3390/ijms18010020
173. NRCE Annual Report (2010). National Research Central on Equines, Annual Report 2009-2010. 21 pp. Available online at: http://nrce.gov.in/downloads/NRCE%20Annual%20Report%202009-10.pdf
174. OIE (2008). Equine Influenza. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 2.5.7 (Paris: Office International Des Epizooties), 871-883
175. Oishi, K., Yamayoshi, S., and Kawaoka, Y. (2018). Identification of novel amino acid residues of influenza virus PA-X that are important for PA-X shut off activity by using yeast. Virology 516, 71-75. doi: 10.1016/j.virol.2018.01.004
176. Olsen, C. W. (2000). DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza. Vet. Microbiol. 74, 149-164. doi: 10.1016/S0378-1135(00)00175-9
177. Oxburgh, L., and Hagström, A. (1999). A PCR based method for the identification of equine influenza virus from clinical samples. Vet. Microbiol. 67, 161-174. doi: 10.1016/S0378-1135(99)00041-3
178. Oxburgh, L., and Klingeborn, B. (1999). Cocirculation of two distinct lineages of equine influenza virus subtype H3N8. J. Clin. Microbiol. 37, 3005-3009
179. Ozaki, H., Sugita, S., and Kida, H. (2000). A rapid and sensitive method for diagnosis of equine influenza by antigen detection using immuno-PCR. Jap. J. Vet. Res. 48, 187-195
180. Paillot, R. (2014). A systematic review of recent advances in equine influenza vaccination. Vaccines 2, 797-831. doi: 10.3390/vaccines2040797
181. Paillot, R., and El-Hage, C. M. (2016). The use of a recombinant canary pox-based equine influenza vaccine during the 2007 Australian outbreak: a systematic review and summary. Pathogens 5:42. doi: 10.3390/pathogens5020042
182. Paillot, R., Grimmett, H., Elton, D., and Daly, J. M. (2008). Protection, systemic IFNγ, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host. Vet. Res. 39:1. doi: 10.1051/vetres:2007062
183. Paillot, R., Hannant, D., Kydd, J. H., and Daly, J. M. (2006b). Vaccination against equine influenza: quid novi? Vaccine 24, 4047-4061. doi: 10.1016/j.vaccine.2006.02.030
184. Paillot, R., Kydd, J. H., Sindle, T., Hannant, D., Edlund Toulemonde, C., Audonnet, J. C., et al. (2006a). Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus. Vet. Immunol. Immunopathol. 112, 225-233. doi: 10.1016/j.vetimm.2006.02.007
185. Paillot, R., Lemaitre, L., Dancer, A., Thibault, J.-C., and Minke, J (2014), Development efficacy of the recombinant canarypox-based equine influenza (EI) vaccine updated according to the last OIE expert surveillance panel recommendations. Equine Vet. J. 46:14. doi: 10.1111/evj.12323_29
186. Paillot, R., Marcillaud Pitel, C., D'Ablon, X., and Pronost, S. (2017). Equine vaccines: How, when and why? Report of the vaccinology session, French Equine Veterinarians Association, 2016. Reims. Vaccines 5, 1-11. doi: 10.3390/vaccines5040046
187. Paillot, R., and Prowse, L. (2012). ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse. Vet. Immunol. Immunopathol. 145, 516-521. doi: 10.1016/j.vetimm.2011.11.019
188. Paillot, R., Prowse, L., Donald, C., Medcalf, E., Montesso, F., Bryant, N., et al. (2010). Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding. Vet. Immunol. Immunopathol. 136, 272-83. doi: 10.1016/j.vetimm.2010.03.019
189. Paillot, R., Prowse, L., Montesso, F., Huang, C. M., Barnes, H., and Escala, J (2013a) Whole inactivated equine influenza vaccine: efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis duration of humoral immunity. Vet. Microbiol. 162, 396-407. doi: 10.1016/j.vetmic.2012.10.019
190. Paillot, R., Prowse, L., Montesso, F., Stewart, B., Jordon, L., Newton, J. R., et al. (2013b). Duration of equine influenza virus shedding and infectivity in immunised horses after experimental infection with EIV A/eq2/Richmond/1/07. Vet. Microbiol. 166, 22-34. doi: 10.1016/j.vetmic.2013.04.027
191. Park, A. W., Daly, J. M., Lewis, N. S., Smith, D. J., Wood, J. L. N., and Grenfell, B. T. (2009). Quantifying the impact of immune escape on transmission dynamics of influenza. Science 326, 726-728. doi: 10.1126/science.1175980
192. Park, A. W., Wood, J. L. N., Newton, J. R., Daly, J., Mumford, J. A., and Grenfell, B. T. (2003). Optimizing vaccination strategies in equine influenza. Vaccine 21, 2862-2870. doi: 10.1016/S0264-410X(03)00156-7
193. Parrish, C. R., Murcia, P. R., and Holmes, E. C. (2015). Influenza virus reservoirs and intermediate hosts: dogs, horses, and new possibilities for influenza virus exposure of humans. J. Virol. 89, 2990-2994. doi: 10.1128/JVI.03146-14
194. Paterson, D., and Fodor, E. (2012). Emerging roles for the influenza A virus nuclear export protein (NEP). PLoS Pathog. 8:e1003019. doi: 10.1371/journal.ppat.1003019
195. Patterson-Kane, J. C., Carrick, J. B., Axon, J. E., Wilkie, I., and Beegg, A. P. (2008). Thee pathology of bronchointerstitial pneumonia in young foals associated with the first outbreak of equine influenza in Australia. Equine Vet. J. 40, 199-203. doi: 10.2746/042516408X292214
196. Pavulraj, S., Bera, B. C., Joshi, A., Anand, T., Virmani, M., Vaid, R. K., et al. (2015). Pathology of equine influenza virus (H3N8) in murine model. PLoS ONE 10:e0143094. doi: 10.1371/journal.pone.0143094
197. Pavulraj, S., Virmani, N., Bera, B. C., Joshi, A., Anand, T., Virmani, M., et al. (2017). Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model. Vet. Microbiol. 210, 188-196. doi: 10.1016/j.vetmic.2017.08.013
198. Pecoraro, H. L., Bennett, S., Garretson, K., Quintana, A. M., Lunn, K. F., and Landolt, G. A. (2013). Comparison of the infectivity and transmission of contemporary canine and equine H3N8 influenza viruses in dogs. Vet. Med. Int. 2013:874521. doi: 10.1155/2013/874521
199. Perglione, C. O., Golemba, M. D., Torres, C., and Barrandeguy, M. (2016). Molecular epidemiology and spatio-temporal dynamics of the H3N8 equine influenza virus in South America. Pathogens 5:61. doi: 10.3390/pathogens5040061
200. Perkins, N. R., Webster, W. R., Wright, T., Denney, I., and Links, I. (2011). Vaccination program in the response to the 2007 equine influenza outbreak in Australia. Aust. Vet. J. 89, 126-134. doi: 10.1111/j.1751-0813.2011.00766.x
201. Prasad, M., Lambe, U. P., Brar, B., Shah, I., Manimegalai, J., Ranjan, K., et al. (2018). Nanotherapeutics: an insight into healthcare and multi-dimensional applications in medical sector of the modern world. Biomed. Pharmacother. 97, 1521-1537. doi: 10.1016/j.biopha.2017.11.026
202. Purzycka, M., Rozek, W., and Zmudzinski, J. F. (2004). Global distribution of equine influenza. Med. Weter. 60, 675-679
203. Qi, T., Guo, W., Huang, W. Q., Li, H. M., Zhao, L. P., Dai, L. L., et al. (2010). Genetic evolution of equine influenza viruses isolated in China. Arch. Virol. 155, 1425-1432. doi: 10.1007/s00705-010-0724-y
204. Quinlivan, M., Zamarin, D., García-Sastre, A., Cullinane, A., Chambers, T., and Palese, P. (2005). Attenuation of equine influenza viruses through truncations of the NS1 protein. J. Virol. 79, 8431-8439. doi: 10.1128/JVI.79.13.8431-8439.2005
205. Radostits, O. M., Gay, C. C., Blood, D. C., and Hinchcliff, K. W. (2003). "Equine influenza, " in Veterinary Medicine, A Text Book of Diseases of Cattle, Sheep, Pigs, Goats and Horses, 9th Edn (New York, NY: Elsevier Saunders), 1144-1147
206. Rash, A., Morton, R., Woodward, A., Maes, O., McCauley, J., Bryant, N., et al. (2017). Evolution and divergence of H3N8 equine influenza viruses circulating in the United Kingdom from 2013 to 2015. Pathogens 6:6. doi: 10.3390/pathogens6010006
207. Read, A. J., Arzey, K. E., Finlaison, D. S., Gu, X., Davis, R. J., Ritchie, L., et al. (2012). A prospective longitudinal study of naturally infected horses to evaluate the performance characteristics of rapid diagnostic tests for equine influenza virus. Vet. Microbiol. 156, 246-255. doi: 10.1016/j.vetmic.2011.10.031
208. Rivailler, P., Perry, I. A., Jang, Y., Davis, C. T., Chen, L. M., Dubovi, E. J., et al. (2010). Evolution of canine and equine influenza (H3N8) viruses co-circulating between 2005 and 2008. Virology 408, 71-79. doi: 10.1016/j.virol.2010.08.022
209. Rodriguez, L., Reedy, S., Nogales, A., Murcia, P. R., Chambers, T. M., and Martinez-Sobrido, L. (2018). Development of a novel equine influenza virus live-attenuated vaccine. Virology 516, 76-85. doi: 10.1016/j.virol.2018.01.005
210. Rosanowski, S. M., Cogger, N., Rogers, C. W., and Stevenson, M. A. (2016). Evaluating the effectiveness of strategies for the control of equine influenza virus in the New Zealand equine population. Transbound Emerg. Dis. 63, 321-332. doi: 10.1111/tbed.12277
211. Rozek, W., Kwasnik, M., and Zmudzinski, J. F. (2011). Detection of antibodies against equine influenza virus by cell based enzyme-linked immunosorbent assay. Bull. Vet. Inst. Pulawy 55, 569-574
212. Sack, A., Daramragchaa, U., Chuluunbaatar, M., Gonchigoo, B., Bazartseren, B., Tsogbadrakh, N., et al. (2017). Low prevalence of enzootic equine influenza virus among horses in Mongolia. Pathogens 6:61. doi: 10.3390/pathogens6040061
213. Sajid, M., Ahmad, M. U., Khan, M. A., Anjum, M. A., and Mushtaq, M. H. (2013). Investigation of equine influenza virus in two geographical regions of Pakistan. Trop. Anim. Health Prod. 45, 693-694. doi: 10.1007/s11250-012-0247-5
214. Schemann, K., Firestone, S. M., Taylor, M. R., Toribio, J. A., Ward, M. P., and Dhand, N. K. (2012). Horse owners'/managers' perceptions about effectiveness of biosecurity measures based on their experiences during the 2007 equine influenza outbreak in Australia. Prev. Vet. Med. 106, 97-107. doi: 10.1016/j.prevetmed.2012.01.013
215. Scocco, P., and Pedini, V. (2008). Localization of influenza virus sialoreceptors in equine respiratory tract. Histol. Histopathol. 23, 973-978. doi: 10.14670/HH-23.973
216. Shi, W., Lei, F., Zhu, C., Sievers, F., and Higgins, D. G. (2010). A complete analysis of HA and NA genes of influenza A viruses. PLoS ONE 5:e14454. doi: 10.1371/journal.pone.0014454
217. Short, K. R., Richard, M., Verhagen, J. H., van Riel, D., Schrauwen, E. J., van den Brand, J. M., et al. (2015). One health, multiple challenges: The inter-species transmission of influenza A virus. One Health 1, 1-13. doi: 10.1016/j.onehlt.2015.03.001
218. Slater, J., and Hannant, D. (2000). Equine immunity to viruses. Vet. Clin. N. Am. Equine Pract. 16, 49-68. doi: 10.1016/S0749-0739(17)30118-9
219. Smyth, B. (2007). Equine influenza: an update. Aust. Vet. J. 85, 14 & 16
220. Soboll, G., Horohov, D. W., Aldridge, B. M., Olsen, C. W., McGregor, M. W., Drape, R. J., et al. (2003). Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination. Vet. Immunol. Immunopathol. 94, 47-62. doi: 10.1016/S0165-2427(03)00060-6
221. Soboll, G., Hussey, S. B., Minke, J. M., Landolt, G. A., Hunter, J. S., Jagannatha, S., et al. (2010). Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination. Vet. Immunol. Immunopathol. 135, 100-107. doi: 10.1016/j.vetimm.2009.11.007
222. Solórzano, A., Foni, E., Córdoba, L., Baratelli, M., Razzuoli, E., Bilato, D., et al. (2015). Cross-species infectivity of H3N8 influenza virus in an experimental infection in swine. J. Virol. 89, 11190-11202. doi: 10.1128/JVI.01509-15
223. Sovinova, O., Tumova, B., Pouska, F., and Nemec, J. (1958). Isolation of a virus causing respiratory disease in horses. Acta Virol. 2, 51-61
224. Sreenivasan, C. C., Jandhyala, S. S., Luo, S., Hause, B. M., Thomas, M., Knudsen, D. E. B., et al. (2018). Phylogenetic analysis and characterization of a sporadic isolate of equine influenza A H3N8 from an unvaccinated horse in 2015. Viruses 10:E31. doi: 10.3390/v10010031
225. Stack, J. C., Murcia, P. R., Grenfell, B. T., Wood, J. L., and Holmes, E. C. (2013). Inferring the inter-host transmission of influenza A virus using patterns of intrahost genetic variation. Proc. Biol. Sci. 280:20122173. doi: 10.1098/rspb.2012.2173
226. Su, S., Wang, L., Fu, X., He, S., Hong, M., Zhou, P., et al. (2014). Equine influenza A(H3N8) virus infection in cats. Emerg. Infect. Dis. 20, 2096-2099. doi: 10.3201/eid2012.140867
227. Suzuki, Y. (2000). Receptor sialylsugar chains as determinants of host range of influenza viruses. Nippon Rinsho 58, 2206-2210
228. Sylte, M. J., and Suarez, D. L. (2009). "Influenza neuraminidase as a vaccine antigen, " in Vaccines for Pandemic Influenza. Current Topics in Microbiology and Immunology, Vol. 333, ed R. Compans and W. Orenstein (Berlin; Heidelberg: Springer)
229. Tabynov, K., Kydyrbayev, Z., Ryskeldinova, S., Assanzhanova, N., Kozhamkulov, Y., Inkarbekov, D., et al. (2014). Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine. Aust. Vet. J. 92, 450-457. doi: 10.1111/avj.12248
230. Takahashi, T., Unuma, S., Kawagishi, S., Kurebayashi, Y., Takano, M., Yoshino, H., et al. (2016). Substrate specificity of equine and human influenza A virus sialidase to molecular species of sialic acid. Biol. Pharm. Bull. 39, 1728-1733. doi: 10.1248/bpb.b16-00345
231. Timoney, P. J. (1996). Equine influenza. Comp. Immunol. Microbiol. Infect. Dis. 19, 205-211. doi: 10.1016/0147-9571(96)00006-9
232. Townsend, H. G., Penner, S. J., Watts, T. C., Cook, A., Bogdan, J., Haines, D. M., et al. (2001). Efficacy of a cold-adapted, intranasal, equine influenza vaccine-challenge trials. Equine Vet. J. 33, 637-643. doi: 10.2746/042516401776249354
233. Townsend, H. G. G., Cook, A., and Watts, T. C. (1999). Efficacy of a cold-adapted, modified-live virus influenza vaccine: a double-blind challenge trial. Proc. Am. Assoc. Equine Pract. 45, 41-42
234. Tu, J., Zhou, H., Jiang, T., Li, C., Zhang, A., Guo, X., et al. (2009). Isolation and molecular characterization of equine H3N8 influenza viruses from pigs in China. Arch. Virol. 154, 887-890. doi: 10.1007/s00705-009-0381-1
235. Uppal, P. K., and Yadav, M. P. (1987). Outbreak of equine influenza in India. Vet. Rec. 121, 569-570
236. Uppal, P. K., Yadav, M. P., and Oberoi, M. S. (1989). Isolation of A/Equi-2 virus during 1987 equine influenza epidemic in India. Equine Vet. J. 21, 364-366. doi: 10.1111/j.2042-3306.1989.tb02690.x
237. Uppal, P. K., Yadav, M. P., and Sharma, S. N. (1987). Occurrence of equine influenza outbreaks in India. Indian J. Comp. Microbiol. Immunol. Infect. Dis. 8, 91-94
238. Van de Walle, G. R., May, M. A., Peters, S. T., Metzger, S. M., Rosas, C. T., and Osterrieder, N. (2010). A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus. Vaccine 28, 1048-1055. doi: 10.1016/j.vaccine.2009.10.123
239. van Maanen, C., and Cullinane, A. (2002). Equine influenza virus infections: an update. Vet. Quart. 24, 79-94. doi: 10.1080/01652176.2002.9695127
240. Virmani, N., Bera, B. C., Gulati, B. R., Karuppusamy, S., Singh, B. K., Kumar Vaid, R., et al. (2010a). Descriptive epidemiology of equine influenza in India (2008-2009): temporal and spatial trends. Vet. Ital. 46, 449-458
241. Virmani, N., Bera, B. C., Shanumugasundaram, K., Singh, B. K., Gulati, B. R., Singh, R. K., et al. (2011). Genetic analysis of the matrix and non-structural genes of equine influenza virus (H3N8) from epizootic of 2008-2009 in India. Vet. Microbiol. 152, 169-175. doi: 10.1016/j.vetmic.2011.04.011
242. Virmani, N., Bera, B. C., Singh, B. K., Shanmugasundaram, K., Gulati, B. R., Barua, S., et al. (2010b). Equine influenza outbreak in India (2008-09): virus isolation, sero-epidemiology and phylogenetic analysis of HA gene. Vet. Microbiol. 143, 224-237 doi: 10.1016/j.vetmic.2009.12.007
243. Virmani, N., Singh, B. K., Gulati, B. R., and Kumar, S. (2008). Equine influenza outbreak in India. Vet. Rec. 163, 607-608. doi: 10.1136/vr.163.20.607-a
244. Waddel, G. H., Teigland, M. B., and Sigel, M. M. (1963). A new influenza virus associated with equine respiratory disease. J. Am. Vet. Med. Assoc. 143, 587-590
245. Wang, C., Wang, Q., Hu, J., Sun, H., Pu, J., Liu, J., et al. (2017). A multiplex RT-PCR assay for detection and differentiation of avian-origin canine H3N2, equine-origin H3N8, human-origin H3N2, and H1N1/2009 canine influenza viruses. PLoS ONE 12:e0170374. doi: 10.1371/journal.pone.0170374
246. Watson, J., Daniels, P., Kirkland, P., Carroll, A., and Jeggo, M. (2011). The 2007 outbreak of equine influenza in Australia: lessons learned for international trade in horses. Rev. Sci. Tech. 30, 87-93. doi: 10.20506/rst.30.1.2021
247. Webby, R. J., Webster, R. G., and Richt, J. A. (2007). Influenza viruses in animal wildlife populations. Curr. Top. Microbiol. Immunol. 315, 67-83. doi: 10.1007/978-3-540-70962-6_4
248. Webster, R. G. (1993). Are equine 1 influenza viruses still present in horses? Equine Vet. J. 25, 537-538. doi: 10.1111/j.2042-3306.1993.tb03009.x
249. Whitlock, F., Rash, A., and Elton, D. (2018). Equine influenza: evolution of a highly infectious virus. Vet. Rec. 182, 710-711. doi: 10.1136/vr.k2727
250. Wilson, W. D. (1993). Equine influenza. Vet. Clin. N. Am. Equine Pract. 9, 257-282. doi: 10.1016/S0749-0739(17)30395-4
251. Wise, H. M., Foeglein, A., Sun, J., Dalton, R. M., Patel, S., Howard, W., et al. (2009). A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J. Virol. 83, 8021-8031. doi: 10.1128/JVI.00826-09
252. Wood, J., and Mumford, J. (1992). Epidemiology of equine influenza. Vet. Rec. 130:126. doi: 10.1136/vr.130.6.126-c
253. Wood, J. M., Schild, G. C., Folkers, C., Mumford, J., and Newman, R. W. (1983). The standardisation of inactivated equine influenza vaccines by single-radial immunodiffusion. J. Biol. Standard. 11, 133-136. doi: 10.1016/S0092-1157(83)80037-7
254. Woodward, A., Rash, A. S., Medcalf, E., Bryant, N. A., and Elton, D. M. (2015). Using epidemics to map H3 equine influenza virus determinants of antigenicity. Virology 481, 187-198. doi: 10.1016/j.virol.2015.02.027
255. Woodward, A. L., Rash, A. S., Blinman, D., Bowman, S., Chambers., T. M., Daly, J. M., et al. (2014). Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010-2012. Vet. Microbiol. 169, 113-127. doi: 10.1016/j.vetmic.2013.11.039
256. Xie, T., Anderson, B. D., Daramragchaa, U., Chuluunbaatar, M., and Gray, G. C. (2016). A review of evidence that equine influenza viruses are zoonotic. Pathogens 5:50. doi: 10.3390/pathogens5030050
257. Yamanaka, T., Bannai, H., Nemoto, M., Tsujimura, K., Kondo, T., Muranaka, M., et al. (2012b). Efficacy of a single intravenous dose of the neuraminidase inhibitor peramivir in the treatment of equine influenza. Vet. J. 193, 358-362. doi: 10.1016/j.tvjl.2012.01.005
258. Yamanaka, T., Cullinane, A., Gildea, S., Bannai, H., Nemoto, M., Tsujimura, K., et al. (2015). The potential impact of a single amino-acid substitution on the efficacy of equine influenza vaccines. Equine Vet. J. 47, 456-462. doi: 10.1111/evj.12290
259. Yamanaka, T., Nemoto, M., Bannai, H., Tsujimura, K., Kondo, T., Matsumura, T., et al. (2012a). No evidence of horizontal infection in horses kept in close contact with dogs experimentally infected with canine influenza A virus (H3N8). Acta Vet. Scand. 54:25. doi: 10.1186/1751-0147-54-25
260. Yamanaka, T., Nemoto, M., Bannai, H., Tsujimura, K., Kondo, T., Matsumura, T., et al. (2016a). Evaluation of twenty-two rapid antigen detection tests in the diagnosis of equine influenza caused by viruses of H3N8 subtype. Influenza Other Respir. Viruses 10, 127-133. doi: 10.1111/irv.12358
261. Yamanaka, T., Nemoto, M., Bannai, H., Tsujimura, K., Kondo, T., Matsumura, T., et al. (2016b). Assessment of antigenic difference of equine influenza virus strains by challenge study in horses. Influenza Other Respir. Viruses 10, 536-539. doi: 10.1111/irv.12418
262. Yamanaka, T., Nemoto, M., Bannai, H., Tsujimura, K., Kondo, T., Matsumura, T., et al. (2017a). Rapid diagnosis of equine influenza by highly sensitive silver amplification immunochromatography system. J. Vet. Med. Sci. 79, 1061-1063. doi: 10.1292/jvms.17-0105
263. Yamanaka, T., Nemoto, M., Bannai, H., Tsujimura, K., Matsumura, T., Kokado, H., et al. (2017b). Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan. J. Vet. Med. Sci. 80, 382-386. doi: 10.1292/jvms.17-0538
264. Yamanaka, T., Nemoto, M., Tsujimura, K., Kondo, T., and Matsumura, T. (2009). Interspecies transmission of equine influenza virus (H3N8) to dogs by close contact with experimentally infected horses. Vet. Microbiol. 139, 351-355. doi: 10.1016/j.vetmic.2009.06.015
265. Yamanaka, T., Niwa, H., Tsujimura, K., Kondo, T., and Matsumura, T. (2008a). Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. J. Vet. Med. Sci. 70, 623-625. doi: 10.1292/jvms.70.623
266. Yamanaka, T., Tsujimura, K., Kondo, T., and Matsumura, T. (2008b). Evaluation of antigen detection kits for diagnosis of equine influenza. J. Vet. Med. Sci. 70, 189-192. doi: 10.1292/jvms.70.189
267. Yamanaka, T., Tsujimura, K., Kondo, T., Matsumura, T., Ishida, H., Kiso, M., et al. (2010). Infectivity and pathogenicity of canine H3N8 influenza A virus in horses. Influenza Other Respir. Viruses 4, 345-351. doi: 10.1111/j.1750-2659.2010.00157.x
268. Yang, H., Xiao, Y., Meng, F., Sun, F., Chen, M., Cheng, Z., et al. (2018). Emergence of H3N8 equine influenza virus in donkeys in China in 2017. Vet. Microbiol. 214, 1-6. doi: 10.1016/j.vetmic.2017.11.033
269. Yates, P., and Mumford, J. A. (2000). Equine influenza vaccine efficacy: the significance of antigenic variation. Vet. Microbiol. 74, 173-177. doi: 10.1016/S0378-1135(00)00177-2
270. Ye, J., Xu, Y., Harris, J., Sun, H., Bowman, A. S., Cunningham, F., et al. (2013). Mutation from arginine to lysine at the position 189 of hemagglutinin contributes to the antigenic drift in H3N2 swine influenza viruses. Virology 446, 225-229. doi: 10.1016/j.virol.2013.08.004
271. Yin, X., Lu, G., Guo, W., Qi, T., Ma, J., Zhu, C., et al. (2014). Identification of equine influenza virus infection in Asian wild horses (Equus przewalskii). Arch. Virol. 159, 1159-1162. doi: 10.1007/s00705-013-1908-z
272. Yondon, M., Heil, G. L., Burks, J. P., Zayat, B., Waltzek, T. B., Jamiyan, B. O., et al. (2013). Isolation and characterization of H3N8 equine influenza A virus associated with the 2011 epizootic in Mongolia. Influenza Other Respir. Viruses 7, 659-665. doi: 10.1111/irv.12069
273. Yondon, M., Zayat, B., Nelson, M. I., Heil, G. L., Anderson, B. D., Lin, X., et al. (2014). Equine influenza A (H3N8) virus isolated from Bactrian camel, Mongolia. Emerg. Infect. Dis. 20, 2144-2147. doi: 10.3201/eid2012.140435